BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16817835)

  • 1. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.
    Manner H; May A; Miehlke S; Dertinger S; Wigginghaus B; Schimming W; Krämer W; Niemann G; Stolte M; Ell C
    Am J Gastroenterol; 2006 Aug; 101(8):1762-9. PubMed ID: 16817835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.
    Hage M; Siersema PD; van Dekken H; Steyerberg EW; Haringsma J; van de Vrie W; Grool TE; van Veen RL; Sterenborg HJ; Kuipers EJ
    Gut; 2004 Jun; 53(6):785-90. PubMed ID: 15138203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium.
    Basu KK; Pick B; Bale R; West KP; de Caestecker JS
    Gut; 2002 Dec; 51(6):776-80. PubMed ID: 12427775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Argon Plasma Coagulation for the Ablation of Barrett's Esophagus: A Systemic Review and Meta-Analysis.
    Kozyk M; Kumar L; Strubchevska K; Trivedi M; Wasvary M; Giri S
    Gut Liver; 2024 May; 18(3):434-443. PubMed ID: 37800316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment of Barrett´s esophagus.
    Varas Lorenzo M; Abad Belando R
    Rev Esp Enferm Dig; 2024 Jan; ():. PubMed ID: 38258761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Management of Dysplastic Barrett's Oesophagus and Early Oesophageal Adenocarcinoma.
    Eusebi LH; Telese A; Castellana C; Engin RM; Norton B; Papaefthymiou A; Zagari RM; Haidry R
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus hybrid argon plasma coagulation in Barrett's esophagus: a prospective randomised trial.
    Knabe M; Wetzka J; Welsch L; Richl J; Michael F; Blößer S; Heilani M; Kronsbein H; May A
    Surg Endosc; 2023 Oct; 37(10):7803-7811. PubMed ID: 37605011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is "Cold" and What Is "Hot" in Mucosal Ablation for Barrett's Oesophagus-Related Dysplasia: A Practical Guide.
    Spadaccini M; Alfarone L; Chandrasekar VT; Maselli R; Capogreco A; Franchellucci G; Massimi D; Fugazza A; Colombo M; Carrara S; Facciorusso A; Bhandari P; Sharma P; Hassan C; Repici A
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art management of dysplastic Barrett's esophagus.
    Vantanasiri K; Iyer PG
    Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argon Plasma Coagulation of Gastric Inlet Patches of the Cervical Esophagus Relieves Vocal and Respiratory Symptoms in Selected Patients.
    Brechmann T; Mühlenkamp M; Schmiegel W; Viebahn B
    Dig Dis Sci; 2023 May; 68(5):1936-1943. PubMed ID: 36376579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett's esophagus: US pilot study.
    Shimizu T; Samarasena JB; Fortinsky KJ; Hashimoto R; El Hage Chehade N; Chin MA; Moosvi Z; Chang KJ
    Endosc Int Open; 2021 Dec; 9(12):E1870-E1876. PubMed ID: 34917455
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic therapies for Barrett's esophagus.
    Ventre S; Shahid H
    Transl Gastroenterol Hepatol; 2021; 6():62. PubMed ID: 34805584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of endoscopic therapy for Barrett's esophagus.
    Condon A; Muthusamy VR
    Ther Adv Gastrointest Endosc; 2021; 14():26317745211051834. PubMed ID: 34708204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insidious presentation and challenging management of esophageal perforation following diagnostic and therapeutic interventions.
    Lampridis S; Mitsos S; Hayward M; Lawrence D; Panagiotopoulos N
    J Thorac Dis; 2020 May; 12(5):2724-2734. PubMed ID: 32642181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma.
    Rouphael C; Anil Kumar M; Sanaka MR; Thota PN
    Therap Adv Gastroenterol; 2020; 13():1756284820924209. PubMed ID: 32523628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic management of esophageal cancer.
    Ahmed O; Ajani JA; Lee JH
    World J Gastrointest Oncol; 2019 Oct; 11(10):830-841. PubMed ID: 31662822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues and controversies in esophageal inlet patch.
    Ciocalteu A; Popa P; Ionescu M; Gheonea DI
    World J Gastroenterol; 2019 Aug; 25(30):4061-4073. PubMed ID: 31435164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and safety of atmospheric low-temperature plasma on bacterial reduction in chronic wounds and wound size reduction: A systematic review and meta-analysis.
    Assadian O; Ousey KJ; Daeschlein G; Kramer A; Parker C; Tanner J; Leaper DJ
    Int Wound J; 2019 Feb; 16(1):103-111. PubMed ID: 30311743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?
    Singh T; Sanaka MR; Thota PN
    World J Gastrointest Endosc; 2018 Sep; 10(9):165-174. PubMed ID: 30283599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-thermal ablation of non-neoplastic Barrett's esophagus with the novel EndoRotor® resection device.
    Knabe M; Blößer S; Wetzka J; Ell C; May A
    United European Gastroenterol J; 2018 Jun; 6(5):678-683. PubMed ID: 30083329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.